We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $468M
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+6.67%
3 Year Est. Return
+57.25%
5 Year Est. Return
+83.16%
10 Year Est. Return
+253.32%
AUM
$766M
AUM Growth
+$94.4M
Cap. Flow
+$70.2M
Cap. Flow %
9.16%
Top 10 Hldgs %
34.82%
Holding
91
New
24
Increased
10
Reduced
32
Closed
6

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$30.4M
2
BG icon
Bunge Global
BG
+$28.2M
3
CHKP icon
Check Point Software Technologies
CHKP
+$21.5M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$17.4M
5
CAG icon
Conagra Brands
CAG
+$12M

Top Sells

Rank Stock Value
1
DWA
DREAMWORKS ANIMATION SKG INC CL-A
DWA
+$17.1M
2
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
+$16.6M
3
T icon
AT&T
T
+$12.2M
4
PEP icon
PepsiCo
PEP
+$10.4M
5
ADM icon
Archer Daniels Midland
ADM
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 20.26%
2 Technology 16.11%
3 Financials 13.68%
4 Energy 12.49%
5 Consumer Staples 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHI
1
DELISTED
Baker Hughes
BHI
$30.1M 3.92%
612,375
+161,989
+36% +$7.81M
CAH icon
2
Cardinal Health
CAH
$57.5B
$29.8M 3.89%
571,716
-66,955
-10% -$3.4M
TEVA icon
3
Teva Pharmaceuticals
TEVA
$42.4B
$29.5M 3.85%
+780,584
New +$30.4M
BG icon
4
Bunge Global
BG
$22.8B
$28.2M 3.68%
+371,670
New +$28.2M
MSFT icon
5
Microsoft
MSFT
$3.71T
$27M 3.52%
810,671
+190,176
+31% +$6.26M
FCX icon
6
Freeport-McMoran
FCX
$104B
$26.2M 3.42%
793,158
-59,393
-7% -$1.82M
PNC icon
7
PNC Financial Services
PNC
$98B
$24.8M 3.24%
342,351
-3,034
-0.9% -$226K
R icon
8
Ryder
R
$9.53B
$24.7M 3.23%
414,468
-20,665
-5% -$1.24M
APA icon
9
APA Corp
APA
$15B
$24.4M 3.18%
286,103
-79,501
-22% -$6.6M
MET icon
10
MetLife
MET
$62B
$22.1M 2.88%
527,130
-50,681
-9% -$2.18M
CHKP icon
11
Check Point Software Technologies
CHKP
$14B
$21.7M 2.83%
+383,488
New +$21.5M
CAG icon
12
Conagra Brands
CAG
$7.43B
$20M 2.61%
847,050
+443,164
+110% +$12M
PPL
13
PPL Corp
PPL
$26.4B
$19.4M 2.53%
685,531
-47,853
-7% -$1.37M
MOS icon
14
The Mosaic Company
MOS
$8.22B
$18.3M 2.39%
425,734
-2,143
-0.5% -$99.8K
JNJ icon
15
Johnson & Johnson
JNJ
$663B
$17.7M 2.31%
204,087
-45,399
-18% -$4.07M
WBA
16
DELISTED
Walgreens Boots Alliance
WBA
$17.6M 2.3%
327,280
+47,176
+17% +$2.37M
COV
17
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$17.4M 2.27%
+285,693
New +$17.4M
AVT icon
18
Avnet
AVT
$7.56B
$17.2M 2.25%
413,330
-152,262
-27% -$5.88M
MDT icon
19
Medtronic
MDT
$120B
$17.1M 2.24%
321,683
-69,214
-18% -$3.72M
DVN icon
20
Devon Energy
DVN
$52.9B
$16.3M 2.12%
281,540
+35,623
+14% +$2.04M
ORCL icon
21
Oracle
ORCL
$457B
$16.1M 2.1%
484,450
-56,060
-10% -$1.82M
JBL icon
22
Jabil
JBL
$32.5B
$15M 1.96%
691,330
-90,420
-12% -$2.06M
DBD
23
DELISTED
Diebold Nixdorf Incorporated
DBD
$12.9M 1.69%
439,938
+269,818
+159% +$8.46M
RGA icon
24
Reinsurance Group of America
RGA
$16.5B
$12.7M 1.65%
189,105
+57,202
+43% +$3.86M
NSC icon
25
Norfolk Southern
NSC
$74B
$12.4M 1.61%
159,912
+39,330
+33% +$2.95M
1
2 3 4

Similar funds

GC
Guidance Capital Lousville, Kentucky $468M AUM 26.09% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $468M AUM 42.57% 1-Year Est. Return
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $468M AUM 19.67% 1-Year Est. Return
BAM
Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return
QFA
Quattro Financial Advisors The Woodlands, Texas $468M AUM 13.49% 1-Year Est. Return
TOCUITCONY
Trustees of Columbia University in the City of New York New York $468M AUM 20.53% 1-Year Est. Return
MAM
Mystic Asset Management Warwick, Rhode Island $468M AUM 30.94% 1-Year Est. Return

Foyston, Gordon, & Payne's Q3 2013 Portfolio in Review

As of Q3 2013, Foyston, Gordon, & Payne held 91 positions worth $766M, up 14% from $672M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Foyston, Gordon, & Payne deployed $70.2M of net new capital in Q3 2013, opening 24 new positions and adding to 10 existing holdings. Its largest new stake was Teva Pharmaceuticals: 780,584 shares worth $29.5M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was DREAMWORKS ANIMATION SKG INC CL-A, an estimated $17.1M trimmed.

  • Foyston, Gordon, & Payne's largest Q3 2013 buy was Teva Pharmaceuticals: 780,584 shares worth $29.5M.
  • Foyston, Gordon, & Payne added most to Conagra Brands in Q3 2013, an estimated $12M increase.
  • Foyston, Gordon, & Payne's biggest Q3 2013 reduction was DREAMWORKS ANIMATION SKG INC CL-A, cutting an estimated $17.1M.
  • Foyston, Gordon, & Payne fully exited MCGRAW-HILL FINANCIAL INC COM in Q3 2013, selling an estimated $16.6M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 35% of its $766M portfolio in Q3 2013.
  • Foyston, Gordon, & Payne opened 24 new positions and closed 6 in Q3 2013.
  • Foyston, Gordon, & Payne's portfolio value rose 14% quarter-over-quarter to $766M.

Based on Foyston, Gordon, & Payne's 13F filing for Q3 2013, filed 13 Nov 2013.